PROCEPT BioRobotics Corporation Increase (Decrease) in Accrued Salaries
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Accrued Salaries of -$2.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedSalaries · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for the quarter ending 2026-06-30 was $1.96M, a 49.43% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for the quarter ending 2026-03-31 was -$4.69M.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for the quarter ending 2025-12-31 was $1.38M, a 48.83% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for the quarter ending 2025-09-30 was $5.46M, a 38.03% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for fiscal 2025 was $1.59M, a 65.82% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for fiscal 2024 was $4.65M, a 35.31% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for fiscal 2023 was $3.44M, a 50.69% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in accrued salaries for fiscal 2022 was $6.97M, a 280.15% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Salaries 3 month | Increase (Decrease) in Accrued Salaries 6 month | Increase (Decrease) in Accrued Salaries 9 month | Increase (Decrease) in Accrued Salaries 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.73M 10-Q · filed 2026-08-05 | -$1.34M derived: sum of 3 quarters · filed 2026-08-05 | $4.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$4.69M 10-Q · filed 2026-04-30 | -$3.31M derived: sum of 2 quarters · filed 2026-04-30 | $2.15M derived: sum of 3 quarters · filed 2026-04-30 | $3.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.84M derived: sum of 2 quarters · filed 2026-02-26 | $8.15M derived: sum of 3 quarters · filed 2026-08-05 | $1.59M 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.77M derived: sum of 2 quarters · filed 2026-08-05 | $207.00K 10-Q · filed 2025-11-05 | $2.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$5.25M 10-Q · filed 2026-08-05 | -$2.54M derived: sum of 3 quarters · filed 2026-08-05 | $1.41M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$6.56M 10-Q · filed 2026-04-30 | -$3.86M derived: sum of 2 quarters · filed 2026-04-30 | $94.00K derived: sum of 3 quarters · filed 2026-04-30 | $3.51M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.66M derived: sum of 2 quarters · filed 2026-02-26 | $10.07M derived: sum of 3 quarters · filed 2026-02-26 | $4.65M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.37M derived: sum of 2 quarters · filed 2025-11-05 | $1.95M 10-Q · filed 2025-11-05 | $5.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$2.00M 10-Q · filed 2025-08-07 | $1.62M derived: sum of 3 quarters · filed 2026-02-26 | $4.93M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$5.42M 10-Q · filed 2025-05-02 | -$1.80M derived: sum of 2 quarters · filed 2026-02-26 | $1.52M derived: sum of 3 quarters · filed 2026-02-26 | $4.06M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.93M derived: sum of 2 quarters · filed 2026-02-26 | $9.48M derived: sum of 3 quarters · filed 2026-02-26 | $3.44M 10-K · filed 2026-02-26 |
| 2023-09-30 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $5.86M derived: sum of 2 quarters · filed 2024-10-28 | -$182.00K 10-Q · filed 2024-10-28 | $2.98M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$3.50M 10-Q · filed 2024-08-02 | -$335.00K derived: sum of 3 quarters · filed 2025-02-27 | $3.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$6.04M 10-Q · filed 2024-05-02 | -$2.88M derived: sum of 2 quarters · filed 2025-02-27 | $502.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.82M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.54M derived: sum of 2 quarters · filed 2025-02-27 | $8.86M derived: sum of 3 quarters · filed 2025-02-27 | $6.97M 10-K · filed 2025-02-27 |
| 2022-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $5.70M derived: sum of 2 quarters · filed 2023-11-02 | $3.81M 10-Q · filed 2023-11-02 | $5.41M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $431.00K 10-Q · filed 2023-07-28 | $2.03M derived: sum of 3 quarters · filed 2024-02-28 | $2.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$1.89M 10-Q · filed 2023-05-04 | -$290.00K derived: sum of 2 quarters · filed 2024-02-28 | $598.00K derived: sum of 3 quarters · filed 2024-02-28 | $760.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.49M derived: sum of 2 quarters · filed 2024-02-28 | $2.65M derived: sum of 3 quarters · filed 2024-02-28 | $1.83M 10-K · filed 2024-02-28 |
| 2021-09-30 | $888.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.05M derived: sum of 2 quarters · filed 2022-11-04 | $235.00K 10-Q · filed 2022-11-04 | $1.23M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$653.00K 10-Q · filed 2022-08-05 | $342.00K derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | -$815.00K 10-Q · filed 2022-05-06 | $180.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $995.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $2.30M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $1.31M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |